Hoth Therapeutics
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -2,648 | -2,605 | -4,105 | -2,199 |
Net Income | -2,692 | -2,688 | -4,105 | -2,199 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -3,050 | -2,150 | -2,492 | -2,372 |
Cash | 4,047 | 6,247 | 7,847 | 9,014 |
Basic Shares | 15,792 | 15,514 | 13,787 | 13,180 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -66 | |||
EBITDA | -11,110 | 27 | -153 | -10,678 |
EBIT | -8,188 | -7,845 | -21,744 | |
Net Income | -12,469 | -8,188 | -7,845 | -11,371 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -9,803 | -6,978 | -8,447 | -9,371 |
Cash | 6,247 | 7,038 | 9,292 | 6,428 |
Basic Shares | 13,805 | 6,375 | 3,409 | 1,197 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | -$0.16 |
2025-09-30 | -$0.30 |
2025-06-30 | -$0.17 |
2025-03-31 | -$0.27 |